{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:26:03Z","timestamp":1787765163974,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cardiovascular diseases (CVDs) are a leading cause of global mortality, motivating research into novel approaches for their management. Lipoprotein(a) (Lp(a)), a unique lipoprotein particle, has been implicated in atherosclerosis and thrombosis, suggesting its potential as a therapeutic target for CVDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study aimed to investigate the association of Lp(a) levels with various cardiovascular parameters and events among patients with confirmed cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>A prospective study was conducted, enrolling 600 participants, predominantly comprising males (79%), with a mean age of 52.78 \u00b1 0.412 years diagnosed with cardiovascular disease. The follow-up was done for 18 months. Patient demographics, blood investigations, and occurrence of major adverse cardiac events (MACE) were collected. SPSS version 21 was used to statistically analyze the relationships between elevated Lp(a) levels and factors such as age, glycated hemoglobin, mortality, MACE, cardiac death, target vessel revascularization, and stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study revealed significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) associations between elevated Lp(a) levels and advanced age, increased glycated hemoglobin levels, as well as occurrences of all-cause mortality, MACE, cardiac death, target vessel revascularization, and stroke. Notably, a significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), association between high Lp(a) levels and acute coronary syndrome (ACS) emerged, suggesting Lp(a)\u2019s role in advanced cardiac events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The findings highlight the potential significance of Lp(a) as a notable risk factor in cardiovascular health. The observed associations between elevated Lp(a) and adverse cardiovascular events, including ACS, underscore its pathogenic role. Consequently, this study supports the rationale for further research into Lp(a)-specific therapeutic interventions, offering substantial promise in refining the management strategies for cardiovascular diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aca.aca_88_23","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T05:00:23Z","timestamp":1705122023000},"page":"32-36","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Confounding Factors Responsible for Elevated Lp(a) Levels in Patients with Coronary Artery Disease"],"prefix":"10.4103","volume":"27","author":[{"given":"Navaneeth","family":"Amin","sequence":"first","affiliation":[{"name":"Department of Cardiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Devasia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobha Ullas","family":"Kamath","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Paramasivam","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad Narayana","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesha N. S.","family":"Prakash","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"R1-20240901","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019:Update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R2-20240901","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1161\/CIR.0000000000000570","article-title":"Projected costs of informal caregiving for cardiovascular disease:2015 to 2035: A policy statement from the American heart association","volume":"137","author":"Dunbar","year":"2018","journal-title":"Circulation"},{"key":"R3-20240901","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.114.008729","article-title":"Cardiovascular diseases in India:Current epidemiology and future directions","volume":"133","author":"Prabhakaran","year":"2016","journal-title":"Circulation"},{"key":"R4-20240901","doi-asserted-by":"crossref","first-page":"2517013","DOI":"10.1155\/2019\/2517013","article-title":"Dyslipidemia associated with hypertension increases the risks for coronary heart disease:A case-control study in Harapan Kita Hospital, National cardiovascular center, Jakarta","volume":"2019","author":"Ariyanti","year":"2019","journal-title":"J Lipids"},{"key":"R5-20240901","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12944-020-01204-y","article-title":"Dyslipidemia and cardiovascular disease risk among the MASHAD study population","volume":"19","author":"Hedayatnia","year":"2020","journal-title":"Lipids Health Dis"},{"key":"R6-20240901","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2967\/jnumed.107.038661","article-title":"Role of inflammation in atherosclerosis","volume":"48","author":"Spagnoli","year":"2007","journal-title":"J Nucl Med"},{"key":"R7-20240901","doi-asserted-by":"crossref","first-page":"711453","DOI":"10.3389\/fcvm.2021.711453","article-title":"Plaque erosion:A distinctive pathological mechanism of acute coronary syndrome","volume":"8","author":"Luo","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"(Suppl 4)","key":"R8-20240901","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ihj.2014.12.001","article-title":"Consensus statement on management of dyslipidemia in Indian subjects","volume":"66","author":"Chandra","year":"2014","journal-title":"Indian Heart J"},{"key":"R9-20240901","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1253\/circj.CJ-20-1037","article-title":"New trends in dyslipidemia treatment","volume":"85","author":"Jang","year":"2021","journal-title":"Circ J"},{"key":"R10-20240901","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A new serum type system in man-the LP system","volume":"59","author":"Berg","year":"1963","journal-title":"Acta Pathol Microbiol Scand"},{"key":"R11-20240901","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MOL.0000000000000070","article-title":"Lipoprotein(a) metabolism","volume":"25","author":"Lamon-Fava","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"R12-20240901","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"R13-20240901","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jamacardio.2020.2413","article-title":"Effect of C-reactive protein on Lipoprotein(a)-associated cardiovascular risk in optimally treated patients with high-risk vascular disease:A prespecified secondary analysis of the ACCELERATE trial","volume":"5","author":"Puri","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R14-20240901","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","article-title":"Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease","volume":"32","author":"Gurdasani","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R15-20240901","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Response to letter regarding article, \u201cLipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk:An analysis from the JUPITER trial (justification for the use of statins in prevention:An intervention trial evaluating rosuvastatin)\u201d","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"key":"R16-20240901","first-page":"833","article-title":"Chinese guideline for the management of dyslipidemia in adults","volume":"44","author":"Adults","year":"2016","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"R17-20240901","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12872-022-02618-5","article-title":"The correlation between lipoprotein(a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL-C levels","volume":"22","author":"Zhu","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"R18-20240901","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.numecd.2022.03.024","article-title":"Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention:A large cohort study","volume":"32","author":"Cui","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R19-20240901","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2022.06.1023","article-title":"Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age:The Copenhagen general population study","volume":"355","author":"Simony","year":"2022","journal-title":"Atherosclerosis"},{"key":"R20-20240901","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1023\/A:1015599129080","article-title":"Joint effects of alcohol consumption and cigarette smoking on atherogenic lipid and lipoprotein profiles:Results from a study of Chinese male population in Taiwan","volume":"17","author":"Wu","year":"2001","journal-title":"Eur J Epidemiol"},{"key":"R21-20240901","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/ajkd.2002.36319","article-title":"Association of kidney function with serum lipoprotein(a) level:The third national health and nutrition examination survey (1991-1994)","volume":"40","author":"Kovesdy","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R22-20240901","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","article-title":"Cardiovascular mortality risk in chronic kidney disease:Comparison of traditional and novel risk factors","volume":"293","author":"Shlipak","year":"2005","journal-title":"JAMA"},{"key":"R23-20240901","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.arcmed.2004.08.003","article-title":"Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lp(a) levels according to thyroid function status","volume":"35","author":"Lee","year":"2004","journal-title":"Arch Med Res"},{"key":"R24-20240901","first-page":"15992","article-title":"The relationship between Lipoprotein a and glycosylated hemoglobin and the degree of coronary artery stenosis in non-diabetic coronary heart disease patients","volume":"21","author":"Xuejin","year":"2019","journal-title":"Biomed J Sci Techn Res"},{"key":"R25-20240901","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"R26-20240901","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227054","article-title":"Lipoprotein(a) plasma levels are not associated with survival after acute coronary syndromes:An observational cohort study","author":"Roth","year":"2020","journal-title":"PLoS ONE"},{"key":"R27-20240901","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.amjcard.2016.08.067","article-title":"Impact of Lipoprotein(a) on long-term outcomes in patients with diabetes mellitus who underwent percutaneous coronary intervention","volume":"118","author":"Konishi","year":"2016","journal-title":"Am J Cardiol"},{"key":"R28-20240901","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.hjc.2020.09.016","article-title":"The role of Lipoprotein(a) in cardiovascular disease:Current concepts and future perspectives","volume":"61","author":"Vavuranakis","year":"2020","journal-title":"Hellenic J Cardiol"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_88_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:01:58Z","timestamp":1787763718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_88_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_88_23","relation":{},"ISSN":["0971-9784","0974-5181"],"issn-type":[{"value":"0971-9784","type":"print"},{"value":"0974-5181","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-06-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}